TY - JOUR
T1 - Uncovering the Rosetta Stone
T2 - Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical
AU - Bix, Gregory J.
AU - Fraser, Justin F.
AU - Mack, William J.
AU - Carmichael, S. Thomas
AU - Perez-Pinzon, Miguel
AU - Offner, Halina
AU - Sansing, Lauren
AU - Bosetti, Francesca
AU - Ayata, Cenk
AU - Pennypacker, Keith R.
N1 - Publisher Copyright:
© 2018, The Author(s).
PY - 2018/6/1
Y1 - 2018/6/1
N2 - The first annual Stroke Translational Research Advancement Workshop (STRAW), entitled “Uncovering the Rosetta Stone: Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical” was held at the University of Kentucky on October 4–5, 2017. This workshop was organized by the Center for Advanced Translational Stroke Science. The workshop consisted of 2 days of activities. These included three presentations establishing the areas of research in stroke therapeutics, discussing the routes for translation from bench to bedside, and identifying successes and failures in the field. On day 2, grant funding opportunities and goals for the National Institute for Neurological Diseases and Stroke were presented. In addition, the meeting also included break-out sessions designed to connect researchers in areas of stroke, and to foster potential collaborations. Finally, the meeting concluded with an open discussion among attendees led by a panel of experts.
AB - The first annual Stroke Translational Research Advancement Workshop (STRAW), entitled “Uncovering the Rosetta Stone: Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical” was held at the University of Kentucky on October 4–5, 2017. This workshop was organized by the Center for Advanced Translational Stroke Science. The workshop consisted of 2 days of activities. These included three presentations establishing the areas of research in stroke therapeutics, discussing the routes for translation from bench to bedside, and identifying successes and failures in the field. On day 2, grant funding opportunities and goals for the National Institute for Neurological Diseases and Stroke were presented. In addition, the meeting also included break-out sessions designed to connect researchers in areas of stroke, and to foster potential collaborations. Finally, the meeting concluded with an open discussion among attendees led by a panel of experts.
KW - Animal models
KW - Brain ischemia
KW - Clinical trials
KW - Reverse translation
KW - Thrombectomy
UR - http://www.scopus.com/inward/record.url?scp=85045098227&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045098227&partnerID=8YFLogxK
U2 - 10.1007/s12975-018-0628-9
DO - 10.1007/s12975-018-0628-9
M3 - Comment/debate
C2 - 29633156
AN - SCOPUS:85045098227
SN - 1868-4483
VL - 9
SP - 258
EP - 266
JO - Translational Stroke Research
JF - Translational Stroke Research
IS - 3
ER -